{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T18:47:17Z","timestamp":1747162037264,"version":"3.40.5"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T00:00:00Z","timestamp":1703808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ihj.2023.12.012","type":"journal-article","created":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T07:38:00Z","timestamp":1703835480000},"page":"S83-S85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["Dyslipidaemia in endocrine disorders"],"prefix":"10.1016","volume":"76","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5867-5073","authenticated-orcid":false,"given":"Kalyani","family":"Sridharan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2023.12.012_bib1","doi-asserted-by":"crossref","DOI":"10.7573\/dic.212514","article-title":"Lipocrinology - the relationship between lipids and endocrine function","volume":"7","author":"Kalra","year":"2018","journal-title":"Drugs Context"},{"key":"10.1016\/j.ihj.2023.12.012_bib2","series-title":"Endotext [Internet]","article-title":"The effect of endocrine disorders on lipids and lipoproteins","author":"Feingold","year":"2000"},{"issue":"6","key":"10.1016\/j.ihj.2023.12.012_bib3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.5603\/EP.a2019.0041","article-title":"Endocrine diseases as causes of secondary hyperlipidemia","volume":"70","author":"\u0141","year":"2019","journal-title":"Endokrynol Pol"},{"issue":"12","key":"10.1016\/j.ihj.2023.12.012_bib4","doi-asserted-by":"crossref","first-page":"dgaa674","DOI":"10.1210\/clinem\/dgaa674","article-title":"Lipid management in patients with endocrine disorders: an endocrine society clinical practice guideline","volume":"105","author":"Newman","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.ihj.2023.12.012_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4103\/2230-8210.91211","article-title":"Hypertriglyceridemia-induced recurrent acute pancreatitis: a case-based review","volume":"16","author":"Kota","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ihj.2023.12.012_bib6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.mayocp.2020.01.011","article-title":"Comparison of transatlantic approaches to lipid management: the AHA\/ACC\/multisociety guidelines vs the ESC\/EAS guidelines","volume":"95","author":"Singh","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ihj.2023.12.012_bib7","doi-asserted-by":"crossref","first-page":"j2099","DOI":"10.1136\/bmj.j2099","article-title":"Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study","volume":"357","author":"Hippisley-Cox","year":"2017","journal-title":"BMJ"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483223004819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483223004819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T01:38:12Z","timestamp":1712626692000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483223004819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":7,"alternative-id":["S0019483223004819"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2023.12.012","relation":{},"ISSN":["0019-4832"],"issn-type":[{"type":"print","value":"0019-4832"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dyslipidaemia in endocrine disorders","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2023.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier, a division of RELX India, Pvt. Ltd on behalf of Cardiological Society of India.","name":"copyright","label":"Copyright"}]}}